Correlation Engine 2.0
Clear Search sequence regions


Sirolimus, a potent inhibitor of B- and T-cell activation. is a commonly used immunosuppressant after renal transplantation. Withdrawal of sirolimus from the immunosuppression regimen may reduce B-cell surveillance. We present a case of rapidly progressive central nervous system (CNS) polymorphic Epstein-Barr virus (EBV)-related post-transplant lymphoproliferative disorder following the withdrawal of sirolimus.

Citation

Marc Mendelson, Zunaid Barday, Roland Eastman, David Le Feuvre, Sally Candy, Hue-Tsi Wu, Charles Swanepoel. Rapidly progressive post-transplant lymphoproliferative disease following withdrawal of sirolimus. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 2012 Dec;102(12):924-6

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 23498038

View Full Text